5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

Authors: Pedro E. Martinez, David R. Rubinow, Lynnette K. Nieman, Deloris E. Koziol, A. Leslie Morrow, Crystal Edler Schiller, Dahima Cintrón, Karla Thompson, Khursheed Khine, Peter J. Schmidt - Neuropsychopharmacology 2015 cited by 145